Cargando…
Immunotherapy in breast cancer
The idea of using the immune system to fight cancer is over 100 years old. A new molecular approach led to a better understanding of the immune system. Checkpoint regulation, understanding the roles of Tregs, Th1, and Th2, development of Chimeric antigen receptor (CAR)-T cells, as well as regulation...
Autores principales: | Bayraktar, Soley, Batoo, Sameer, Okuno, Scott, Glück, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540776/ https://www.ncbi.nlm.nih.gov/pubmed/31160888 http://dx.doi.org/10.4103/jcar.JCar_2_19 |
Ejemplares similares
-
Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancer
por: Batoo, Sameer, et al.
Publicado: (2019) -
Circulating tumor cells in breast cancer
por: Pukazhendhi, Geetha, et al.
Publicado: (2014) -
Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review
por: Bayraktar, Soley, et al.
Publicado: (2010) -
Patient Understanding of Chemotherapy and Goals of Care as Provided by Different Care Team Members
por: Suhail, Shanzay, et al.
Publicado: (2023) -
Esophageal cancer presenting with atrial fibrillation: A case report
por: Bayraktar, Ulas Darda, et al.
Publicado: (2008)